NDC Package 10631-006-31 Absorica Ld

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
10631-006-31
Package Description:
3 BLISTER PACK in 1 BOX / 10 CAPSULE in 1 BLISTER PACK
Product Code:
Proprietary Name:
Absorica Ld
Usage Information:
ABSORICA and ABSORICA LD are indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, ABSORICA and ABSORICA LD are reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics.Limitations of Use:If a second course of ABSORICA/ABSORICA LD therapy is needed, it is not recommended before a two-month waiting period because the patient’s acne may continue to improve following a 15 to 20-week course of therapy [see Dosage and Administration (2.2)].
11-Digit NDC Billing Format:
10631000631
NDC to RxNorm Crosswalk:
Labeler Name:
Sun Pharmaceutical Industries, Inc.
Sample Package:
No
FDA Application Number:
NDA211913
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
11-20-2019
End Marketing Date:
11-20-2019
Listing Expiration Date:
11-20-2019
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 10631-006-31?

The NDC Packaged Code 10631-006-31 is assigned to a package of 3 blister pack in 1 box / 10 capsule in 1 blister pack of Absorica Ld, labeled by Sun Pharmaceutical Industries, Inc.. The product's dosage form is and is administered via form.

Is NDC 10631-006 included in the NDC Directory?

No, Absorica Ld with product code 10631-006 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Sun Pharmaceutical Industries, Inc. on November 20, 2019 and its listing in the NDC Directory is set to expire on November 20, 2019 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 10631-006-31?

The 11-digit format is 10631000631. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-210631-006-315-4-210631-0006-31